Filing Details
- Accession Number:
- 0001415889-21-005600
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-01 11:06:56
- Reporting Period:
- 2021-11-29
- Accepted Time:
- 2021-12-01 11:06:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1035354 | Eloxx Pharmaceuticals Inc. | ELOX | Services-Commercial Physical & Biological Research (8731) | 841368850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1314756 | E. Daniel Geffken | C/O Eloxx Pharmaceuticals, Inc. 480 Arsenal Way, Suite 130 Watertown MA 02472 | Interim Cfo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-29 | 50,000 | $0.72 | 50,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Price represents the average purchase price per share.
Billionaire Hedge Funds
